Project Search Results

Select

Research Categorization

Operator
Operator

Project Details

Operator
Operator

Contact Researcher and Awardee Organization

Operator
Operator

Funding Organization

Operator
Operator
Operator
Operator
ListGraphMap
Displaying 1 - 10 of 62 Projects
Project # Contact PI Funding Organization Fiscal Year
Assessing poly(GP) proteins as clinical and pharmacodynamic biomarkers of C9ORF72-associated FTD
2019-005 PETRUCELLI, LEONARD The Association for Frontotemporal Degeneration 2019
Non-invasive brain stimulation to restore cortical plasticity and connectivity in genetic and sporadic FTD
AFTD-Borroni-2018 Borroni, Barbara The Association for Frontotemporal Degeneration 2018
Rescue of lysosomal dysfunction, neuroinflammation, and neurodegeneration by lysosomal GRN-2 in a mouse model of PGRN deficiency and frontotemporal dementia
AFTD-Kukar-2017 Kukar, Thomas The Association for Frontotemporal Degeneration 2017
Assessing polyGP proteins as clinical and pharmacodynamic biomarkers of C9ORF72-associated FTD
AFTD-Petrucelli-2017 PETRUCELLI, LEONARD The Association for Frontotemporal Degeneration 2017
Identification of novel biofluid markers of tau and TDP-43 pathology
AFTD-Rohrer-2017 Rohrer, Jonathan The Association for Frontotemporal Degeneration 2017
Using TDP43 as a biomarker in FTD patients
AFTD-Steen-2017 Steen, Judith The Association for Frontotemporal Degeneration 2017
Virtual Reality based Spatial Memory Intervention for patients with Mild Cognitive Impairment
EUJPND-CIHR-Bohbot-365 BOHBOT, Véronique Canadian Institutes of Health Research (CIHR) 2016
Improving Performance in Drivers with Mild Cognitive Impairment: An RCT of Cognitive Training
EUJPND-CIHR-Naglie-448 NAGLIE, Gary Canadian Institutes of Health Research (CIHR) 2016
Chemical-genetics approaches using in vivo models of age-dependent neurodegeneration
EUJPND-CIHR-Parker-452 Parker, Alex J Canadian Institutes of Health Research (CIHR) 2016
Validation of the human farnesyl pyrophosphate synthase (hFPPS) as a therapeutic target and design of pre-clinical candidates for the treatment of multiple myeloma and neurodegenerative diseases.
EUJPND-CIHR-Tsantrizos-487 TSANTRIZOS, Youla S Canadian Institutes of Health Research (CIHR) 2016